Carrie‐Anne Malinczak

This study evaluates the preclinical safety of human lactoferrin alpha, finding it non-genotoxic and non-toxic in juvenile rats at high doses.

This study assesses the 4-week immunotoxicity and toxicokinetics of lactoferrin alpha produced by Komagataella phaffii in rats, finding no toxicologically significant changes at high doses.

The paper assesses the allergenic risk of recombinant human lactoferrin produced in Komagataella phaffii using bioinformatics, glycan analysis, and simulated digestion, finding low allergenic potential.

This study evaluates the oral toxicity of recombinant human lactoferrin in rats at various doses, finding it well-tolerated up to 2000 mg/kg/day.